Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Deminger Medical AB
AB
In liquidation
Org 5591452460
Post-secondary non-tertiary education · NACE 8541
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
SEK 932K
+13% vs 2021
EBITDA margin
-40.6%
-303% vs 2021
Equity ratio
-290.1%
Financial strength
Net profit 2022
SEK -396K
-340% vs 2021
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
SEK 932K
+13%
EBITDA
SEK -379K
-303%
Net profit
SEK -396K
-340%
Total assets
SEK 141K
-34%
Equity
SEK -410K
-2859%
Employees
1
—
Company information
Legal name
Deminger Medical AB
Org number
5591452460
Legal form
Aktiebolag
NACE code
8541 · Post-secondary non-tertiary education
Founded
16 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-11-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall tillhandahålla läkarkompetens för konsultverksamhet och för att ge kurser och föreläsningar
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Post-secondary non-tertiary education
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2018
1M
2019
1M
2020
1M
2021
1M
2022
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
SEK thousands
Item
2018
2019
2020
2021
2022
Revenue
858
939
531
826
932
Staff expenses
—
—
—
−297
−547
EBITDA
7
−37
−163
186
−379
Depreciation & amort.
−4
−8
−16
−16
−16
EBIT
3
−45
−179
170
−395
Net financials
—
—
—
−5
−1
Profit before tax
3
−46
−179
165
−396
Tax
−2
−5
−0
—
—
Net profit
1
−51
−179
165
−396
Balance sheet
SEK thousands
Item
2018
2019
2020
2021
2022
Total assets
507
331
262
213
141
Equity
51
0
−179
−14
−410
Long-term debt
0
0
0
—
—
Short-term debt
456
331
441
227
551
Total debt
456
331
441
227
551
Financial ratios
5-year trend
EBITDA margin
-40.6%
This company
15.8%
Market median
-357% vs market
2018
2022
Equity ratio
-290.1%
This company
38.2%
Market median
-859% vs market
2018
2022
Return on equity
-39567000.0%
This company
18.4%
Market median
-215038143% vs market
2018
2022
Net profit margin
-42.5%
This company
8.1%
Market median
-625% vs market
2018
2022
Asset turnover
6.60×
This company
1.12×
Market median
+489% vs market
2018
2022
Debt / equity
1.34×
This company
0.62×
Market median
-116% vs market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-11-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JL
Jonathan Lars Roine Ramsten
Liquidator
Liquidator
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Deminger Medical AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jonathan Lars Roine Ramsten
Liquidator
0 companies